I reiterate...CXR would not have added 100 sales folks to the previous 75 assigned to US Donnatal product if they were concerned about earnings. This is not the behaviour of a company that is concerned about debt payment risk or meeting guidance. IMO they will meet guidance next Wed and CXR SP will surpass VRX.